A new editorial paper was published in Oncotarget’s Volume 14 on June 12, 2023, entitled, “ERβ as a mediator of estrogen signaling in inflammatory breast cancer.”
Annexon lays out more GA drug data; Okyo Pharma pulls back public offering
In May, Annexon’s drug candidate ANX007 did not prove better at reducing the lesion growth in a leading cause of blindness. Now more data have